VAXICAN Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • IPO
  • (Upcoming)

  • Investors
  • 6

VAXICAN General Information

Description

Developer of therapeutic cancer vaccines designed to strengthen the body's immune response against cancer. The company offers enveloped virus-like particle-based vaccines supported by proprietary machine learning and artificial intelligence technologies, enabling biotechnology companies, research organizations, and healthcare providers to develop immunotherapies for cancer.

Contact Information

Website
www.vaxican.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ul. Kampinoska 25
  • Gdańsk, 80-180
  • Poland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Ul. Kampinoska 25
  • Gdańsk, 80-180
  • Poland

VAXICAN Timeline

202320242025202620272028
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VAXICAN Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. IPO 01-Jun-2028 Upcoming Pre-Clinical Trials
5. Later Stage VC (Series A) 01-Jun-2027 Upcoming Pre-Clinical Trials
4. Later Stage VC 23-Sep-2026 Completed Pre-Clinical Trials
3. Seed Round 19-Nov-2025 Completed Pre-Clinical Trials
2. Accelerator/Incubator 30-Oct-2020 $900K $900K Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2019 Completed Pre-Clinical Trials
To view VAXICAN’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

VAXICAN Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic cancer vaccines designed to strengthen the body's immune response against cancer. The company o
Drug Discovery
Gdańsk, Poland
20 As of 2026

South San Francisco, CA
 

Mainz, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VAXICAN Competitors (6)

One of VAXICAN’s 6 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA
BioNTech Formerly VC-backed Mainz, Germany
Moderna Formerly VC-backed Cambridge, MA
Merck & Co. Corporation Rahway, NJ
Bavarian Nordic Corporation Hellerup, Denmark
To view VAXICAN’s complete competitors history, request access »

VAXICAN Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VAXICAN Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Voolt Corporation Minority
DeepTech Capital Consortium Angel Group Minority
iif.vc Venture Capital Minority
Rubicon Partners (Warsaw) Venture Capital Minority
StartSmart CEE Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

VAXICAN FAQs

  • When was VAXICAN founded?

    VAXICAN was founded in 2019.

  • Where is VAXICAN headquartered?

    VAXICAN is headquartered in Gdańsk, Poland.

  • What is the size of VAXICAN?

    VAXICAN has 20 total employees.

  • What industry is VAXICAN in?

    VAXICAN’s primary industry is Drug Discovery.

  • Is VAXICAN a private or public company?

    VAXICAN is a Private company.

  • What is VAXICAN’s current revenue?

    The current revenue for VAXICAN is .

  • How much funding has VAXICAN raised over time?

    VAXICAN has raised $6.95M.

  • Who are VAXICAN’s investors?

    Voolt, DeepTech Capital Consortium, iif.vc, Rubicon Partners (Warsaw), and StartSmart CEE are 5 of 6 investors who have invested in VAXICAN.

  • Who are VAXICAN’s competitors?

    Genentech, BioNTech, Moderna, Merck & Co., and Bavarian Nordic are some of the 6 competitors of VAXICAN.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process